Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist medicine. To lower A1C, it enhances insulin synthesis (which lowers blood glucose) while inhibiting glucagon production (which raises blo
Founded year: | Not set |
Funding rounds: | Not set |
Total funding amount: | Not set |